To include your compound in the COVID-19 Resource Center, submit it here.

Biotie considering options for SYN118 after Phase IIa data

Biotie Therapies Corp. (HSE:BTH1V) said it does not expect partner UCB Group (Euronext:UCB)

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE